STAT

STAT+: Skylark Bio kicks off new gene therapy trial for deafness

STAT+: Skylark Bio kicks off new gene therapy trial for deafnessWorldPing

Biotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

Tupac Shakur murder trial begins 30 years after rapper's deathWorldPing
France 24

Tupac Shakur murder trial begins 30 years after rapper's death

The trial of a man accused of orchestrating the killing of Tupac Shakur started this week with jury selection, almost 30 years after the rap legend was gunned down near the Las Vegas Strip. FRANCE 24's Wassim Cornet tells us more.

Brief by WorldPing · Original reporting by France 24